000			03946nam a22004455i 4500
999			_c362620 _d362620 _x1
001			362620
003			ES-MaUEC
005			20230102121559.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			210308s2021 gw | o |||| 0|eng d
020			_a9783030652258
024	7		_a10.1007/978-3-030-65225-8 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC112 _b2021 EB
100	1		_aRommes, Hans _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut _9681839
245	1	0	_aSelective Decontamination of the Digestive Tract (SDD) : _bCurrent Guidelines _cby Hans Rommes, Rick van Saene, Miguel A. de la Cal
250			_aFirst edition 2021
264		1	_aCham _bSpringer International Publishing _c2021
300			_a1 recurso en línea (XXXI, 289 páginas) _b45 ilustraciones, 18 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
505	0		_aPart I. The basics -- Introduction -- Microorganisms -- Defense -- Infections -- Infection control -- Enteral and parenteral antimicrobials used in the SDD-policy -- Part II. Clinical microbiology for the ICU team -- Clinical microbiology: an overview -- Surveillance versus diagnostic cultures -- Sampling and microscopy -- Inoculation and culturing -- Naming of microorganisms -- Antibiotic sensitivity testing -- Availability of the clinical microbiological results for the intensivist -- Part III. Therapeutics -- Therapy of bacterial and fungal infections -- Viral infections in the ICU -- Inflammation and hyperinflammation -- Part IV. Surveillance -- Resistance -- Outbreaks -- Appendix -- Appendix 1. General principles before implementing the SDD-strategy -- Appendix 2. Selective decontamination of the digestive tract -- Appendix 3. SDD in Methicillin-resistant S. aureus (MRSA) -- Appendix 4. SDD in Multidrug-resistant Gram-negative bacteria (MDRGNB).
520			_aThis book explains the basic concepts of Selective Decontamination of the Digestive tract (SDD) to help those involved in treating critically ill patients to improve outcomes and the quality of care. SDD has led to major changes in our understanding, the treatment and prevention of infections in critically ill patients over the past 40 years. It is the most studied intervention in intensive care medicine and is the subject of 73 randomized controlled trials, including over 15000 patients and 15 meta-analyses. SDD reduces morbidity and mortality, is cost-effective and safe as SDD does not increase antimicrobial resistance. Correct application of the SDD strategy enables ICU teams to control infections - even in ICUs with endemic antibiotic resistant microorganisms such as methicillin resistant S. aureus (MRSA). Describing the concept and application of SDD, and presenting case studies and microbiological flow charts, this practical guide will appeal to intensivists, critical care practitioners, junior doctors, microbiologists and ICU-nurses as well as infection control specialists and pharmacists. .
988			_aSpringer_Medicine_2021
650		7	_2embne _9138404 _aEnfermedades infecciosas
700	1		_aSaene, Rick van _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut _9681840
700	1		_aCal, M. A. de la _q(Miguel Angel) _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut _9681841
776	0	8	_iPrinted edition: _z9783030652241
776	0	8	_iPrinted edition: _z9783030652265
776	0	8	_iPrinted edition: _z9783030652272
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-65225-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2022 _dz _eb _zSI